FARMINGDALE, N.Y.--(BUSINESS WIRE)--Misonix, Inc. (Nasdaq: MSON), a developer of therapeutic ultrasonic medical device technology for the treatment of cancer and other acute or chronic health conditions, today announced that it has begun selling its SonaStar™ Ultrasonic Surgical Aspiration System into Chile under the auspices of MD International, Inc., a Miami, Florida based distributor of high technology medical devices. To date, four systems have been shipped in anticipation of placing them in hospitals throughout the country.
